NON-SEGMENTAL VITILIGO (NSV)
Clinical trials for NON-SEGMENTAL VITILIGO (NSV) explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO (NSV) trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO (NSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to recolor white patches in vitiligo
Disease control Recruiting nowThis study tests an experimental drug called LY4005130 in 60 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants receive either the drug or a placebo by IV every few weeks for 24 weeks. The goal is to see if the drug can reduce the …
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Massive global study launches to measure hidden toll of skin diseases
Knowledge-focused Recruiting nowThis study aims to understand how alopecia areata, vitiligo, and hidradenitis suppurativa affect the quality of life and daily functioning of teenagers and adults. Researchers will collect information from nearly 2,800 participants across multiple countries using surveys and skin…
Matched conditions: NON-SEGMENTAL VITILIGO (NSV)
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC